Inogen, Inc. (FRA:6IO)
Germany · Delayed Price · Currency is EUR 6.05
-0.05 (-0.82%)
Last updated: Nov 26, 2025, 8:04 AM CET
Inogen Company Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.
The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories.
It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Inogen, Inc.
| Country | United States |
| Founded | 2001 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 766 |
| CEO | Kevin R. Smith |
Contact Details
Address: 859 Ward Drive Goleta, Delaware 93111 United States | |
| Phone | 805 562 0500 |
| Website | inogen.com |
Stock Details
| Ticker Symbol | 6IO |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Kevin R. Smith | Chief Executive Officer |
| Michael Bourque | Chief Financial Officer |
| Philip Corrin | Chief Operating Officer |
| Lorna Williams | Head of Investor Relations |